about
The human steroid hydroxylases CYP1B1 and CYP11B2Spironolactone and risk of upper gastrointestinal events: population based case-control studyChallenging aspects of treatment strategies in heart failure with preserved ejection fraction: "Why did recent clinical trials fail?"Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes3-Pyridyl substituted aliphatic cycles as CYP11B2 inhibitors: aromaticity abolishment of the core significantly increased selectivity over CYP1A2The effect of vitamin d on aldosterone and health status in patients with heart failure.Myocardial changes after spironolactone in spontaneous hypertensive rats. A laser scanning confocal microscopy study.The spironolactone renaissance.Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusThe renin-angiotensin-aldosterone system and vascular remodeling.Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?Aldosterone and cardiovascular remodelling: focus on myocardial failure.Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner.Vascular-targeted therapies for Duchenne muscular dystrophyMechanisms of cardiac fibrosis in hypertension.Inhibition of cytochromes p450: existing and new promising therapeutic targets.The pathogenesis of cardiac fibrosis.Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblastsTherapeutic manipulation of glucocorticoid metabolism in cardiovascular diseaseSpironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufageninBlocking aldosterone in heart failure.PAI-1 in tissue fibrosis.The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly.Is there benefit in dual renin-angiotensin-aldosterone system blockade? No, yes and maybe: a guide for the perplexed.Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: a focus on the cardiomyocyte.Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.Are two drugs better than one? A review of combination therapies for hypertension.Effects of spironolactone in spontaneously hypertensive adult rats subjected to high salt intakeExploring QSAR for CYP11B2 binding affinity and CYP11B2/CYP11B1 selectivity of diverse functional compounds using GFA and G/PLS techniques.Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure.Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling.Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-alpha in normal rats.Comparison of the effects of intrapericardial and intravenous aldosterone infusions on left ventricular fibrosis in rats.Atrial fibrillation in primary aldosteronism.Adrenalectomy improves arterial stiffness in primary aldosteronism.Auto-amplification of cortisol actions in human carotid atheroma is linked to arterial remodeling and stroke.Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.Evaluation of a Pharmacist-Driven Aldosterone Antagonist Stewardship Program in Patients With Heart Failure.Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism.Pharmacophore Modeling and in Silico/in Vitro Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors.
P2860
Q24321759-CDCE6727-780F-461D-A504-5DCAAF7405C3Q24679905-A756293E-A138-48E3-BB8B-D422BDC7B514Q26785931-E6CDEA91-7736-4313-AE8C-3F7368E44236Q28364342-800DE92B-A402-4336-B9DC-B3E64F5DD753Q28484774-75D6BB56-AE2A-4752-913E-F4AD213E334DQ30413123-C68D0EA9-87C6-43FF-B072-A33132B9468BQ31052911-D23A416D-A513-4CF4-96CB-E6238AFD43A4Q33944169-200B4066-9AB7-4D0C-A8D6-9A524C7A5306Q34124779-FDD45DEF-89FF-47A8-957B-EA3CB7EABD1AQ34513169-E9DD4293-53B0-41CE-9D95-935F6AD84DC1Q35640718-A107969F-2CD8-49C3-ADA6-2E5AD3351F89Q35770232-523FCDC4-AA65-4D02-A963-A2625ED62556Q35963179-C232735A-DEDD-45EC-B501-9E81F2990BCFQ36835180-D7CFBCB2-C49D-41AC-9B2F-8BE8B1D9EF98Q36873139-7750141F-2673-423B-92FE-111748AC1C06Q36929602-EC7E7106-D9C6-4017-877D-4C50D39756D4Q37161329-A1E19020-41B1-459D-932A-7D073E85FA10Q37176189-116DD95C-6AE0-42AF-B4AF-22957D99C6BDQ37230796-E7C9D7E0-FAD6-4DA5-95B1-DA445AA1EA8EQ37438192-8B6EF106-A95C-4840-9E41-026E858E0B5BQ37574673-8B3282D3-660A-4C0C-BA28-BFF82036D4DFQ37861626-7A2AFBCB-689E-4F6F-B745-E9B06F85D435Q37977028-8DA33E57-E67C-4A4D-B6B2-CACA5AC3E282Q38076689-76EB6A1D-B687-40A2-B73A-D328E3C37586Q38119546-E767DAA3-2644-481E-A854-AF027A7541C2Q38614176-66A202B3-FFB1-4BA4-80A3-19DB7AB05257Q39106784-8B1F1C6A-0B0B-492D-A224-3AB3160F2355Q41826036-5923992C-FBB1-4C15-BBFD-33ECBEF68BD8Q43210163-C02306F7-1F5D-4890-9ED6-977FD0CD88AAQ43773190-7384F68C-07B7-4ADE-8B26-7E4C14CB7FBEQ44185650-3240E673-16ED-473F-9152-69247CFC79E4Q44654323-2E4919CA-C334-4C99-BB3D-8F22417CC436Q45231099-AA5B3306-A8FB-4812-A7DB-E69F1B00DDB6Q45925619-E1350950-80A9-41EE-8797-EDC576D28A6BQ46463378-C5DF7B6D-6EB3-49A1-95E2-4274646BF697Q46664468-45D88F1E-7170-4A79-A94F-9A9E97B72E20Q46878366-C924C407-2A83-409E-9D92-DDF8A36C9B10Q47323152-89FACDB7-660F-423D-B400-B688A53C4C49Q50027498-5EC4723B-267B-4E57-A156-B6409A8C6B74Q50128659-5B5DA0A9-BC29-4517-BC8D-218433D7BEF9
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Induction of cardiac fibrosis by aldosterone.
@ast
Induction of cardiac fibrosis by aldosterone.
@en
type
label
Induction of cardiac fibrosis by aldosterone.
@ast
Induction of cardiac fibrosis by aldosterone.
@en
prefLabel
Induction of cardiac fibrosis by aldosterone.
@ast
Induction of cardiac fibrosis by aldosterone.
@en
P356
P1476
Induction of cardiac fibrosis by aldosterone.
@en
P2093
P304
P356
10.1006/JMCC.2000.1129
P577
2000-06-01T00:00:00Z